Involvement of the endocannabinoid system in drug addiction

Trends in Neurosciences

Volumn 29, Issue 4, 2006, Pages 225-232

  Maldonado, Rafael ^a   Valverde, Olga ^a   Berrendero, Fernando ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DOPAMINE; ENDOCANNABINOID; MORPHINE; NICOTINE; OPIATE; PSYCHOSTIMULANT AGENT; RIMONABANT;

ALCOHOLISM; BRAIN DEPTH STIMULATION; CANNABIS ADDICTION; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPERIMENTAL MOUSE; GABAERGIC TRANSMISSION; HEROIN DEPENDENCE; HUMAN; MORPHINE ADDICTION; MOTIVATION; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; OPIATE ADDICTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

ANIMALS; APPETITIVE BEHAVIOR; BEHAVIOR, ANIMAL; ENDOCANNABINOIDS; HUMANS; MICE; MICE, KNOCKOUT; NEURONAL PLASTICITY; RATS; RECEPTOR, CANNABINOID, CB1; RECURRENCE; REWARD; SUBSTANCE-RELATED DISORDERS; VENTRAL TEGMENTAL AREA;

EID: 33645982868     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.01.008     Document Type: Review

References (85)

1. Camí J., and Farré M. Drug addiction. N. Engl. J. Med. 349 (2003) 975-986
2. Koob G.F., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
3. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 (2001) 695-703
4. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 (2004) 24-32
5. Maldonado R. Opioid system involvement in cannabinoid tolerance and dependence. In: Maldonado R. (Ed). Molecular Biology of Drug Addiction (2003), Humana Press 221-248
6. Wise R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5 (2004) 483-494
7. Kauer J.A. Learning mechanisms in addiction synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu. Rev. Physiol. 66 (2004) 447-475
8. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
9. Fride E., and Mechoulam R. New advances in the identification and physiological role of the different components of the endogenous cannabinoid system. In: Maldonado R. (Ed). Molecular Biology of Drug Addiction (2003), Humana Press 173-198
10. 2 receptors. Science 310 (2005) 329-332
11. Wilson R.I., and Nicoll R.A. Endocannabinoid signaling in the brain. Science 296 (2002) 678-682
12. Jung K.M., et al. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68 (2005) 1196-1202
13. Melis M., et al. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24 (2004) 53-62
14. Robbe D., et al. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8384-8388
15. Riegel A.C., and Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 24 (2004) 11070-11078
16. 1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21 (2001) 9506-9518
17. Gerdeman G.L., et al. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 (2002) 446-451
18. Chevaleyre V., and Castillo P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43 (2004) 871-881
19. 1 receptor knockout mice. Science 283 (1999) 401-404
20. Lichtman A.H., and Martin B.R. Cannabinoid tolerance and dependence. In: Pertwee R. (Ed). Cannabinoids (2005), Springer-Verlag 691-717
21. 9-tetrahydrocannabinol and nicotine. Br. J. Pharmacol. 135 (2002) 564-578
22. 1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43 (2002) 857-867
23. 1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118 (2001) 61-65
24. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol. 13 (2002) 451-463
25. 1 antagonist, blocks nicotine-conditioned place preferences. NeuroReport 15 (2004) 2139-2143
26. 1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl.) 181 (2005) 722-734
27. 1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology 30 (2005) 145-155
28. De Vries T.J., et al. Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. Behav. Brain Res. 161 (2005) 164-168
29. Balerio G.N., et al. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur. J. Neurosci. 20 (2004) 2737-2748
30. Fernandez J.R., and Allison D.B. Rimonabant Sanofi-Synthelabo. Curr. Opin. Investig. Drugs 5 (2004) 430-435
31. 1 receptor agonist. Eur. J. Pharmacol. 370 (1999) 233-240
32. Colombo G., et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl.) 159 (2002) 181-187
33. 1) receptors. Psychopharmacology (Berl.) 132 (1997) 104-106
34. Wang L., et al. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1393-1398
35. 1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur. J. Neurosci. 21 (2005) 2243-2251
36. McGregor I.S., and Gallate J.E. Rats on the grog: novel pharmacotherapies for alcohol craving. Addict. Behav. 29 (2004) 1341-1357
37. Hungund B.L., et al. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem. 84 (2003) 698-704
38. 1 receptor knockout mice. Neuropharmacology 46 (2004) 243-253
39. 1 receptors. Behav. Brain Res. 164 (2005) 206-213
40. 2 receptors. Neuropsychopharmacology 30 (2005) 339-349
41. 1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J. Neurosci. 23 (2003) 2453-2458
42. López-Moreno J.A., et al. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J. Neurosci. 24 (2004) 8245-8252
43. 9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol Alcohol. 40 (2005) 35-45
44. Maldonado R., and Rodríguez de Fonseca F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22 (2002) 3326-3331
45. Martin M., et al. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci. 12 (2000) 4038-4046
46. 1 receptor knockout mice. Brain Res. 945 (2002) 135-138
47. Navarro M., et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci. 21 (2001) 5344-5350
48. De Vries T.J., et al. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl.) 168 (2003) 164-169
49. 1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther. 306 (2003) 93-102
50. Fattore L., et al. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur. J. Neurosci. 17 (2003) 1723-1726
51. Ghozland S., et al. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci. 22 (2002) 1146-1154
52. Justinova Z., et al. The opioid antagonist naltrexone reduces the reinforcing effects of Δ9 tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology (Berl.) 173 (2003) 186-194
53. Tanda G., et al. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
54. Valverde O., et al. Involvement of endogenous opioid system in cannabinoid responses. Curr. Med. Chem. 4 (2004) 183-193
55. 1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. NeuroReport 9 (1998) 3397-3402
56. Maldonado R. Study of cannabinoid dependence in animals. Pharmacol. Ther. 95 (2002) 153-164
57. Rubino T., et al. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects. J. Neurochem. 93 (2005) 984-991
58. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
59. Tanda G., et al. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3 (2000) 1073-1074
60. 1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl.) 135 (1998) 324-332
61. Vinklerova J., et al. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J. Psychopharmacol. 16 (2002) 139-143
62. 9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl.) 175 (2004) 360-366
63. 1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30 (2005) 1670-1680
64. De Vries T.J., et al. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7 (2001) 1151-1154
65. 1 receptors control conditioned drug seeking. Trends Pharmacol. Sci. 26 (2005) 420-426
66. 1 cannabinoid receptors in the rat amygdala. J. Neurosci. 23 (2003) 10311-10320
67. Wolf M.E., et al. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47 Suppl. 1 (2004) 61-79
68. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 81 (2005) 263-284
69. Lupica C.R., and Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 48 (2005) 1105-1116
70. Robbe D., et al. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001) 109-116
71. 1 receptor antagonists as promising new medications for drug dependence. J. Pharmacol. Exp. Ther. 312 (2005) 875-883
72. González S., et al. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 954 (2002) 73-81
73. 1 receptor binding and mRNA levels. Drug Alcohol Depend. 66 (2002) 77-84
74. Kringelbach M.L. The human orbitofrontal cortex: linking reward to hedonic experience. Nat. Rev. Neurosci. 6 (2005) 691-702
75. Harris G.C., et al. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
76. Zhang P.W., et al. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry 9 (2004) 916-931
77. Hoffman A.F., et al. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 23 (2003) 4815-4820
78. 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 7 (2004) 585-586
79. 9-tetrahydrocannabinol and morphine-dependent mice. J. Pharmacol. Exp. Ther. 298 (2001) 1007-1014
80. Singh M.E., et al. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res. 1026 (2004) 244-253
81. Navarro M., et al. Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats. Eur. J. Pharmacol. 501 (2004) 235-237
82. Caille S., and Parsons L.H. SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats. Eur. J. Neurosci. 18 (2003) 3145-3149
83. Colombo G., et al. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol. 33 (1998) 126-130
84. Freedland C.S., et al. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol. Clin. Exp. Res. 25 (2001) 277-282
85. Lesscher H.M., et al. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol. 15 (2005) 31-37